Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of Human Hepatoblastoma Cells
Lujing Wang(Army Medical University), Jianhui Liu(Chongqing University of Technology)
Cited by 34
Related Papers
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
|Cancer Cell|2024|185
Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress
|Acta Pharmacologica Sinica|2021|171
Trilobatin ameliorates insulin resistance through IRS-AKT-GLUT4 signaling pathway in C2C12 myotubes and ob/ob mice
|Chinese Medicine|2020|25